News from kindred biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 10, 2015, 09:02 ET

Kindred Biosciences Announces Second Quarter 2015 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the second quarter ended June 30, 2015 and provided updates on its...

May 28, 2015, 09:02 ET

KindredBio Announces Appointment of Jennifer Elliott as Vice President of Legal Affairs and Intellectual Property

Kindred Biosciences, Inc. (NASDAQ: KIN) today announced the appointment of Jennifer Elliott as Vice President of Legal Affairs and Intellectual...

May 08, 2015, 09:02 ET

Kindred Biosciences Announces First Quarter 2015 Financial Results

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the first quarter ended March 31, 2015 and provided updates on...

Mar 19, 2015, 09:20 ET

Kindred Biosciences to Present at 2015 Jefferies Animal Health Summit

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Mar 16, 2015, 16:02 ET

Kindred Biosciences Announces Positive Results of Pilot Field Study of KIND-012 for the Control of Fever in Horses

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today...

Mar 12, 2015, 16:01 ET

Kindred Biosciences Announces Fourth Quarter and Year-End 2014 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended December 31, 2014.   Conference Call and...

Mar 03, 2015, 08:30 ET

KindredBio to Announce Fourth Quarter and Year-End 2014 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it...

Dec 03, 2014, 16:01 ET

KindredBio Announces Update on AtoKin and Atopic Dermatitis Program

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Nov 17, 2014, 08:30 ET

KindredBio to Present at Jefferies 2014 Global London Healthcare Conference

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced...

Nov 13, 2014, 16:01 ET

Kindred Biosciences Announces Third Quarter 2014 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended September 30, 2014.   KindredBio today...

Nov 06, 2014, 09:02 ET

Kindred Bio to Announce Third Quarter 2014 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it...

Aug 20, 2014, 16:01 ET

Kindred Biosciences Announces Top-Line Results from Pivotal Study of CereKin in Dogs with Osteoarthritis

Kindred Biosciences, Inc. (KindredBio, NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today...

Aug 13, 2014, 16:01 ET

Kindred Biosciences Announces Second Quarter 2014 Financial Results

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended June 30, 2014. Conference Call and Webcast...

Aug 06, 2014, 09:02 ET

KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data

 Kindred Biosciences, Inc. (KindredBio, NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced...

Jun 11, 2014, 09:01 ET

Kindred Bio to Host Investor Breakfast on June 13 in New York City

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

May 21, 2014, 16:01 ET

Kindred Bio to Present at Craig-Hallum, Stifel, and Jefferies Conferences

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...

May 12, 2014, 16:01 ET

Kindred Biosciences Announces First Quarter 2014 Financial Results and Completion of Enrollment in CereKin Pivotal Study

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended March 31, 2014. In addition, Kindred Bio...

May 06, 2014, 09:03 ET

Kindred Bio to Announce First Quarter 2014 Financial Results on Monday, May 12th

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it...

Apr 08, 2014, 16:01 ET

Kindred Bio Announces Closing of Public Offering and Exercise of Over-Allotment Option

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the closing...

Apr 04, 2014, 09:03 ET

Kindred Bio to Present at Needham 13th Annual Healthcare Conference

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...